Being told you have heart failure with reduced or preserved ejection fraction can be confusing. Here is what ejection fraction means and why the distinction matters for treatment.
BNP and NT-proBNP are blood markers released when the heart is under strain — the primary tests used to diagnose and monitor heart failure. An elevated result is the beginning of an investigation, not a verdict.
Originally developed to lower blood sugar, SGLT2 inhibitors have turned out to be among the most important heart failure medications in a generation.
Modern treatment has transformed heart failure with reduced ejection fraction into one of the most treatable conditions in cardiology. Here is what modern treatment can achieve, and why quadruple therapy is now the standard of care.
Entresto combines two complementary medicines to protect the failing heart in ways older treatments cannot. Here is how it works, what the evidence shows, and what to expect when taking it.
In complete heart block the top and bottom of the heart stop communicating, and a backup rhythm takes over. It is serious, and it is also among the most fixable problems in cardiology.
Cardiac amyloidosis is caused by misfolded proteins stiffening the heart muscle, and it is now treatable. Here is what patients need to know about this increasingly recognised and now treatable condition.
CoQ10 is a widely used supplement, especially among people on statins, but the evidence is more mixed than the marketing suggests. Here is what it can and can’t do, who might benefit, and the interactions that matter if you are on a blood thinner.
ARBs are among the world’s most prescribed heart medicines, and the go-to alternative when ACE inhibitors cause a cough. Here is what an ARB does, what to expect while taking one, and how it protects your heart and kidneys.